Everolimus 10mg Tablets
Everolimus is an mTOR inhibitor used as an antineoplastic for renal cell carcinoma and immunosuppressive for transplant rejection, in 10mg film-coated tablets. Classified in HTS 3004.90.92.16 for dosed immunosuppressive medicaments.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If imported as bulk macrocyclic lactone
Chemical classification under Chapter 29 applies to bulk forms sans dosing.
If part of a clinical trial kit with placebos
Blinded trial kits specifically direct to heading 3006 per chapter notes.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Reference Orange Book patent status to determine generic import eligibility
• Ensure moisture-proof packaging documentation for hygroscopic APIs
Related Products under HTS 3004.90.92.16
Tacrolimus 1mg Capsules
Tacrolimus capsules are immunosuppressive medicaments used to prevent organ transplant rejection, containing 1mg of the active ingredient in hard gelatin capsules for oral measured doses. Classified under HTS 3004.90.92.16 for retail-packed immunosuppressive products.
Mycophenolate Mofetil 500mg Tablets
Mycophenolate mofetil is an immunosuppressive prodrug inhibiting lymphocyte proliferation, used post-transplant in 500mg enteric-coated tablets. Under HTS 3004.90.92.16 for retail-packaged measured medicaments.
Pembrolizumab 100mg/4ml Solution
Pembrolizumab injection is an anti-PD-1 antineoplastic monoclonal antibody for various cancers, in 100mg/4ml vials for IV infusion. HTS 3004.90.92.16 applies to these dosed immunosuppressive therapies.
Imatinib Mesylate 400mg Tablets
Imatinib mesylate tablets are an antineoplastic medicament used primarily for treating chronic myeloid leukemia by inhibiting tyrosine kinase activity. They are put up in measured doses of 400mg per tablet in retail packaging, qualifying under HTS 3004.90.92.16 as an unmixed antineoplastic product for therapeutic use.
Cyclophosphamide 50mg Injection Vials
Cyclophosphamide is an immunosuppressive and antineoplastic agent used in chemotherapy for cancers and autoimmune diseases, supplied in sterile 50mg vials for measured dosing. It fits HTS 3004.90.92.16 as a put-up unmixed product for therapeutic retail sale or hospital use.
Rituximab 100mg/10ml Intravenous Infusion
Rituximab is a monoclonal antibody antineoplastic used for non-Hodgkin lymphoma and rheumatoid arthritis, provided in 100mg/10ml single-use vials for measured IV administration. It qualifies under HTS 3004.90.92.16 as an immunosuppressive biologic in dosed form.